Moderna: We are Working on a Third Experimental Dose Targeting a New Mutated Strain of The Virus

“Moderna” revealed that it is working on a third experimental dose of the Coronavirus vaccine, targeting a new mutated strain of the virus.

The company indicated that it shipped doses of the new vaccine to the National Institutes of Health for clinical trials, explaining that “Moderna is committed to making the largest number of updates to its vaccine as necessary, so that the epidemic is controlled.”

For its part, the American company “Pfizer” indicated that it is conducting experiments for a third dose of the Corona vaccine, to better understand the immune response against the mutated strains.